{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9810649", "DateCompleted": {"Year": "1999", "Month": "01", "Day": "22"}, "DateRevised": {"Year": "2019", "Month": "10", "Day": "24"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0934-8840", "JournalIssue": {"Volume": "283", "Issue": "1", "PubDate": {"Year": "1995", "Month": "Nov"}}, "Title": "Zentralblatt fur Bakteriologie : international journal of medical microbiology", "ISOAbbreviation": "Zentralbl Bakteriol"}, "ArticleTitle": "Respiratory burst of human polymorphonuclear leukocytes in response to the galactoside-specific mistletoe lectin.", "Pagination": {"StartPage": "90", "EndPage": "94", "MedlinePgn": "90-4"}, "Abstract": {"AbstractText": ["The phagocytic activity of human polymorphonuclear leukocytes (PMNLs) towards Staphylococcus aureus Cowan 1 was evaluated in chemiluminescence assays. As to check its activating ability, galactoside-specific mistletoe lectin (ML-1) was coincubated with PMNLs which were then challenged with S. aureus. Statistically significant (p < 0.001) chemiluminescent response (correlating with phagocytic activity) could be demonstrated at optimal experimental condition, viz: 1 x 10(6) PMNLs incubated with 0.005 ng ML-1 for 30 and 60 minutes before S. aureus challenge. Other experimental schedules (different timing and PMNL/ML-1 concentrations) did not present with statistically relevant changes in chemiluminescent response. These studies suggest that optimal ML-1 concentrations enhance the phagocytic activity of PMNLs which might be of benefit in thus treated patients as to prevent (or lower the rate of) infections under antineoplastic therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, Glasgow Caledonian University, Scotland, GB."}], "LastName": "Braun", "ForeName": "J M", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gemmell", "ForeName": "C G", "Initials": "CG"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Beuth", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ko", "ForeName": "H L", "Initials": "HL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Pulverer", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Zentralbl Bakteriol", "NlmUniqueID": "9203851", "ISSNLinking": "0934-8840"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Galactosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Lectins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Lectins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ribosome Inactivating Proteins, Type 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Toxins, Biological"}, {"RegistryNumber": "0", "NameOfSubstance": "ribosome inactivating protein, Viscum"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["immunology"], "DescriptorName": "Galactosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["immunology"], "DescriptorName": "Lectins"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Mistletoe"}, {"QualifierName": ["immunology", "microbiology"], "DescriptorName": "Neutrophils"}, {"QualifierName": [], "DescriptorName": "Plant Lectins"}, {"QualifierName": [], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plant Proteins"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["immunology"], "DescriptorName": "Respiratory Burst"}, {"QualifierName": [], "DescriptorName": "Ribosome Inactivating Proteins, Type 2"}, {"QualifierName": ["immunology"], "DescriptorName": "Staphylococcus aureus"}, {"QualifierName": ["immunology"], "DescriptorName": "Toxins, Biological"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1995", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "2000", "Month": "5", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "1995", "Month": "11", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9810649", "10.1016/s0934-8840(11)80894-7"]}}]}